Raymond James Trust N.A. Seagen Inc. Transaction History

Raymond James Trust N.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$127.59 - $203.08 $137,031 - $218,107	1,074 New	1,074 $217,000
Q2 2022 Jul 14, 2022	SELL	$108.81 - $179.33 $761 - $1,255	-7 Reduced 0.42%	1,646 $291,000
Q4 2021 Jan 31, 2022	SELL	$142.57 - $190.86 $104,361 - $139,709	-732 Reduced 30.69%	1,653 $256,000
Q3 2021 Oct 18, 2021	SELL	$142.45 - $169.82 $3,703 - $4,415	-26 Reduced 1.08%	2,385 $405,000
Q2 2021 Jul 20, 2021	SELL	$135.08 - $161.1 $135 - $161	-1 Reduced 0.04%	2,411 $381,000

Q1 2021 May 03, 2021	BUY	$137.51 - $190.8 $331,674 - $460,209	2,412 New	2,412 $335,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.